4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-005048
Chief Medical Officer gave up 4,678 shares (to pay taxes)
- Chief Medical Officer acquired 11,248 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-01-17 | Option exercise | +11,248 | 32,796 | D: show line 1 in the form | ||
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-01-17 | Shares withheld for taxes | −4,678 | $6.43 | $30,080 | 28,118 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-01-17 | Option exercise · Restricted Stock Units | −11,248 | 22,502 | D: show line 3 in the form |
Loading xslF345X03/tm233853d3_4seq1.xml…